The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.6M data for 1.1M Compounds and 8.9K Targets. Of those, 1,179K data for 544K Compounds and 4.4K Targets were curated by BindingDB curators.

Advanced Search

6 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

Article Title
Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARa Selective Agonist.EBI
Bristol-Myers Squibb Co.
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) Agonist.EBI
Vitae Pharmaceuticals Inc
Discovery of Second Generation ROR? Inhibitors Composed of an Azole Scaffold.EBI
Kyoto Prefectural University of Medicine
Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR)-Selective Agonists: Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(5,5,8,8-tetrahydronaphthalen-2-yl)amino)nicotinic Acid (NEt-TMN).EBI
Arizona State University
Discovery of potent and selective PPAR?/? dual antagonists and initial biological studies.EBI
Inception Sciences
Structure-activity relationship study on benzoic acid part of diphenylamine-based retinoids.EBI
Tohoku Pharmaceutical University